| 12290558 |
SARS-CoV-2 vaccines comprising human adenovirus vectors encoding spike and nucleocapsid-ETSD immunogens |
Patrick Soon-Shiong, Peter Sieling, Kayvan Niazi, Shahrooz Rabizadeh, Lise Geissert +4 more |
2025-05-06 |
| 12285480 |
Method of inducing immunity against SARS-CoV-2 using spike and nucleocapsid-ETSD immunogens delivered by RNA and replication-defective adenoviruses |
Mohit Verma |
2025-04-29 |
| 11857620 |
Method of inducing immunity against SARS-CoV-2 using spike (s) and nucleocapsid (N)-ETSD immunogens delivered by a replication-defective adenovirus |
Patrick Soon-Shiong, Peter Sieling, Kayvan Niazi, Shahrooz Rabizadeh, Lise Geissert +4 more |
2024-01-02 |
| 11573230 |
Rapid verification of virus particle production for a personalized vaccine |
Kayvan Niazi, Frank R. Jones |
2023-02-07 |
| 11352642 |
Methods and compositions for combination immunotherapy |
Frank R. Jones, Elizabeth Gabitzsch, Yvette Latchman |
2022-06-07 |
| 11304998 |
Combination immunotherapies comprising IL-15 superagonists |
Frank R. Jones, Elizabeth Gabitzsch, Yvette Latchman, Joseph P. Balint |
2022-04-19 |
| 11149087 |
Methods and compositions for combination immunotherapy |
Frank R. Jones, Elizabeth Gabitzsch, Yvette Latchman |
2021-10-19 |
| 11104916 |
Compositions and methods for alphavirus vaccination |
Frank R. Jones, Joseph P. Balint, Yvette Latchman, Elizabeth Gabitzsch |
2021-08-31 |
| 11022406 |
Inconspicuous defense substance spray canister |
— |
2021-06-01 |
| 11020467 |
Combination immunotherapies comprising IL-15 superagonists |
Frank R. Jones, Elizabeth Gabitzsch, Yvette Latchman, Joseph P. Balint |
2021-06-01 |
| 10835596 |
Compositions and methods for flavivirus vaccination |
Frank R. Jones, Joseph P. Balint, Yvette Latchman, Elizabeth Gabitzsch |
2020-11-17 |